Please enable JavaScript to continue using this application.

Compare $BHVN vs $GENB | Chartloom

Compare

$BHVN vs $GENB

Biohaven Ltd · Generate Biomedicines Inc

BHVN

Biohaven Ltd

GENB

Generate Biomedicines Inc

Compare $BHVN vs $GENB

Comparing Biohaven Ltd and Generate Biomedicines Inc

BHVNBiohaven Ltd

GENBGenerate Biomedicines Inc

BHVNBiohaven Ltd

Market cap

$1.82B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

113.82x

Rev growth (TTM)

—

YTD performance

11.4%

52W performance

-21.3%

FCF yield

-28.1%

GENBGenerate Biomedicines Inc

Market cap

$1.84B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

72.38x

Rev growth (TTM)

—

YTD performance

13.4%

52W performance

13.4%

FCF yield

-4.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BHVN

GENB

Detailed metrics comparison

BHVN

Biohaven Ltd

GENB

Generate Biomedicines Inc

Market Cap

BHVN$1.82B

GENB$1.84B

Enterprise Value

BHVN$1.84B

GENB$1.71B

Price

BHVN$12.08

GENB$14.34

P/E Ratio

BHVNN/A

GENBN/A

P/S Ratio

BHVN0.00x

GENB135.78x

EV/Sales

BHVN0.00x

GENB126.16x

EV/EBITDA

BHVN0.00x

GENB0.00x

P/B Ratio

BHVN159.05x

GENB3.85x

P/FCF Ratio

BHVNN/A

GENBN/A

EV/FCF

BHVN-3.60x

GENB-19.17x

PEG Ratio

BHVNN/A

GENBN/A

Forward P/E (NTM)

BHVNN/A

GENBN/A

Forward P/S (NTM)

BHVN113.82x

GENB72.38x

Revenue (TTM)

BHVN$0

GENB$14M

Revenue Growth (YoY)

BHVNN/A

GENBN/A

Forward Rev Growth

BHVN169.9%

GENB12.0%

Gross Margin (TTM)

BHVN0.0%

GENB0.0%

Operating Margin (TTM)

BHVN0.0%

GENB0.0%

EBITDA Margin (TTM)

BHVN0.0%

GENB-979.8%

Net Margin (TTM)

BHVN0.0%

GENB-1007.9%

FCF Margin (TTM)

BHVNN/A

GENB-658.3%

Net Income (TTM)

BHVN$-587M

GENB$-136M

FCF (TTM)

BHVN$-512M

GENB$-89M

EPS (TTM)

BHVN-$3.90

GENB-$1.06

ROE (TTM)

BHVN-63995.0%

GENB0.0%

ROA (TTM)

BHVN-13827.0%

GENB0.0%

ROIC (TTM)

BHVN-13277.0%

GENB0.0%

Cash

BHVN$238M

GENB$135M

Debt

BHVN$259M

GENB$5M

Net Cash/Debt

BHVN$-21M

GENB$130M

Current Ratio (TTM)

BHVN4.73x

GENB8.30x

Quick Ratio (TTM)

BHVN4.30x

GENB8.08x

Debt/Equity (TTM)

BHVN21.23x

GENB0.01x

Debt/Assets (TTM)

BHVN0.0%

GENB0.0%

Interest Coverage (TTM)

BHVNN/A

GENBN/A

Net Debt/EBITDA (TTM)

BHVN0.00x

GENB0.00x

Beta

BHVN3.18

GENB0.38

52W Performance

BHVN-21.3%

GENB13.4%

YTD Performance

BHVN11.4%

GENB13.4%

% from 52W High

BHVN-34.9%

GENB-36.7%

% from 52W Low

BHVN61.5%

GENB30.4%

Asset Turnover (TTM)

BHVN0.00x

GENB0.00x

FCF Yield (TTM)

BHVN-28.1%

GENB-4.8%

Earnings Yield (TTM)

BHVN-32.3%

GENB-7.4%

Dividend Yield (TTM)

BHVNN/A

GENBN/A

Rule of 40

BHVN0.0

GENB-658.3

EV/GP/RG

BHVNN/A

GENBN/A

Ticker research

View BHVN research View GENB research

Metric	BHVN Biohaven Ltd	GENB Generate Biomedicines Inc
Market & Valuation
Market Cap	$1.82B	$1.84B
Enterprise Value	$1.84B	$1.71B
Price	$12.08	$14.34
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	135.78x
EV/Sales	0.00x	126.16x
EV/EBITDA	0.00x	0.00x
P/B Ratio	159.05x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.60x	-19.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	113.82x	72.38x
Revenue & Growth
Revenue (TTM)	$0	$14M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	169.9%	12.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-979.8%
Net Margin (TTM)	0.0%	-1007.9%
FCF Margin (TTM)	N/A	-658.3%
Net Income (TTM)	$-587M	$-136M
FCF (TTM)	$-512M	$-89M
EPS (TTM)	-$3.90	-$1.06
ROE (TTM)	-63995.0%	0.0%
ROA (TTM)	-13827.0%	0.0%
ROIC (TTM)	-13277.0%	0.0%
Financial Health
Cash	$238M	$135M
Debt	$259M	$5M
Net Cash/Debt	$-21M	$130M
Current Ratio (TTM)	4.73x	8.30x
Quick Ratio (TTM)	4.30x	8.08x
Debt/Equity (TTM)	21.23x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.18	0.38
52W Performance	-21.3%	13.4%
YTD Performance	11.4%	13.4%
% from 52W High	-34.9%	-36.7%
% from 52W Low	61.5%	30.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-28.1%	-4.8%
Earnings Yield (TTM)	-32.3%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-658.3
EV/GP/RG	N/A	N/A
Ticker research	View BHVN research	View GENB research

Valuation

P/S Ratio

BHVN

0.00x

GENB

135.78x

EV/FCF

GENB

-19.17x

BHVN

-3.60x

Growth & revenue

Forward Revenue Growth

BHVN

169.9%

GENB

12.0%

Profitability & performance

Gross Margin

BHVN

0.0%

GENB

0.0%

ROE

GENB

0.0%

BHVN

-63995.0%

FCF Yield %

GENB

-4.8%

BHVN

-28.1%

52-Week Performance

GENB

13.4%

BHVN

-21.3%

Detailed metrics comparison

BHVN

Biohaven Ltd

GENB

Generate Biomedicines Inc

Market Cap

BHVN$1.82B

GENB$1.84B

Enterprise Value

BHVN$1.84B

GENB$1.71B

Price

BHVN$12.08

GENB$14.34

P/E Ratio

BHVNN/A

GENBN/A

P/S Ratio

BHVN0.00x

GENB135.78x

EV/Sales

BHVN0.00x

GENB126.16x

EV/EBITDA

BHVN0.00x

GENB0.00x

P/B Ratio

BHVN159.05x

GENB3.85x

P/FCF Ratio

BHVNN/A

GENBN/A

EV/FCF

BHVN-3.60x

GENB-19.17x

PEG Ratio

BHVNN/A

GENBN/A

Forward P/E (NTM)

BHVNN/A

GENBN/A

Forward P/S (NTM)

BHVN113.82x

GENB72.38x

Revenue (TTM)

BHVN$0

GENB$14M

Revenue Growth (YoY)

BHVNN/A

GENBN/A

Forward Rev Growth

BHVN169.9%

GENB12.0%

Gross Margin (TTM)

BHVN0.0%

GENB0.0%

Operating Margin (TTM)

BHVN0.0%

GENB0.0%

EBITDA Margin (TTM)

BHVN0.0%

GENB-979.8%

Net Margin (TTM)

BHVN0.0%

GENB-1007.9%

FCF Margin (TTM)

BHVNN/A

GENB-658.3%

Net Income (TTM)

BHVN$-587M

GENB$-136M

FCF (TTM)

BHVN$-512M

GENB$-89M

EPS (TTM)

BHVN-$3.90

GENB-$1.06

ROE (TTM)

BHVN-63995.0%

GENB0.0%

ROA (TTM)

BHVN-13827.0%

GENB0.0%

ROIC (TTM)

BHVN-13277.0%

GENB0.0%

Cash

BHVN$238M

GENB$135M

Debt

BHVN$259M

GENB$5M

Net Cash/Debt

BHVN$-21M

GENB$130M

Current Ratio (TTM)

BHVN4.73x

GENB8.30x

Quick Ratio (TTM)

BHVN4.30x

GENB8.08x

Debt/Equity (TTM)

BHVN21.23x

GENB0.01x

Debt/Assets (TTM)

BHVN0.0%

GENB0.0%

Interest Coverage (TTM)

BHVNN/A

GENBN/A

Net Debt/EBITDA (TTM)

BHVN0.00x

GENB0.00x

Beta

BHVN3.18

GENB0.38

52W Performance

BHVN-21.3%

GENB13.4%

YTD Performance

BHVN11.4%

GENB13.4%

% from 52W High

BHVN-34.9%

GENB-36.7%

% from 52W Low

BHVN61.5%

GENB30.4%

Asset Turnover (TTM)

BHVN0.00x

GENB0.00x

FCF Yield (TTM)

BHVN-28.1%

GENB-4.8%

Earnings Yield (TTM)

BHVN-32.3%

GENB-7.4%

Dividend Yield (TTM)

BHVNN/A

GENBN/A

Rule of 40

BHVN0.0

GENB-658.3

EV/GP/RG

BHVNN/A

GENBN/A

Ticker research

View BHVN research View GENB research

Metric	BHVN Biohaven Ltd	GENB Generate Biomedicines Inc
Market & Valuation
Market Cap	$1.82B	$1.84B
Enterprise Value	$1.84B	$1.71B
Price	$12.08	$14.34
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	135.78x
EV/Sales	0.00x	126.16x
EV/EBITDA	0.00x	0.00x
P/B Ratio	159.05x	3.85x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.60x	-19.17x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	113.82x	72.38x
Revenue & Growth
Revenue (TTM)	$0	$14M
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	169.9%	12.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-979.8%
Net Margin (TTM)	0.0%	-1007.9%
FCF Margin (TTM)	N/A	-658.3%
Net Income (TTM)	$-587M	$-136M
FCF (TTM)	$-512M	$-89M
EPS (TTM)	-$3.90	-$1.06
ROE (TTM)	-63995.0%	0.0%
ROA (TTM)	-13827.0%	0.0%
ROIC (TTM)	-13277.0%	0.0%
Financial Health
Cash	$238M	$135M
Debt	$259M	$5M
Net Cash/Debt	$-21M	$130M
Current Ratio (TTM)	4.73x	8.30x
Quick Ratio (TTM)	4.30x	8.08x
Debt/Equity (TTM)	21.23x	0.01x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.18	0.38
52W Performance	-21.3%	13.4%
YTD Performance	11.4%	13.4%
% from 52W High	-34.9%	-36.7%
% from 52W Low	61.5%	30.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-28.1%	-4.8%
Earnings Yield (TTM)	-32.3%	-7.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-658.3
EV/GP/RG	N/A	N/A
Ticker research	View BHVN research	View GENB research